Anaphylaxis to the first dose of mRNA SARS‐CoV‐2 vaccines: Don't give up on the second dose!

Author:

Krantz Matthew S.1ORCID,Bruusgaard‐Mouritsen Maria A.2ORCID,Koo Grace1,Phillips Elizabeth J.3,Stone Cosby A.1ORCID,Garvey Lene H.2ORCID

Affiliation:

1. Division of Allergy, Pulmonary and Critical Care Medicine Department of Medicine Vanderbilt University School of Medicine Nashville TN USA

2. Department of Dermatology and Allergy Allergy Clinic Copenhagen University Hospital – Herlev and Gentofte Copenhagen Denmark

3. Division of Infectious Diseases Department of Medicine Vanderbilt University Medical Center Nashville TN USA

Funder

Agency for Healthcare Research and Quality

National Institutes of Health

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference5 articles.

1. Interim Clinical Considerations for Use of mRNA COVID‐19 Vaccines | CDC. Published February 10 2021.https://www.cdc.gov/vaccines/covid‐19/info‐by‐product/clinical‐considerations.html. Accessed February 10 2021.

2. Acute Allergic Reactions to mRNA COVID-19 Vaccines

3. Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021

4. Assessing severity of anaphylaxis: a data-driven comparison of 23 instruments

5. Optimizing investigation of suspected allergy to polyethylene glycols;Bruusgaard‐Mouritsen MA;J Allergy Clin Immunol,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3